Advertisement

Topics

NuCana Company Profile

14:14 EST 17th December 2018 | BioPortfolio

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide technology has the potential to set new benchmarks in efficacy and safety with its treatments that are specifically designed to overcome key cancer resistance mechanisms. Acelarin® is NuCana’s lead medicine and was the first ProTide to enter the clinic in October 2010. Acelarin achieved exceptional levels of disease control in a broad range of patients with advanced, rapidly progressing solid tumours. Global Phase III studies with Acelarin are currently being planned in ovarian, biliary and pancreatic cancers. Privately held, NuCana, which raised $57 million in a Series B financing in April 2014, is backed by world-leading investors including Sofinnova Partners, Sofinnova Ventures, Morningside Ventures, Alida Capital International and the Scottish Investment Bank.


News Articles [9 Associated News Articles listed on BioPortfolio]

NuCana plc: NuCana to Participate in the Jefferies 2018 London Healthcare Conference

EDINBURGH, United Kingdom, Nov. 07, 2018 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer p...

NuCana plc: NuCana to Participate in Citi's 2018 Global Healthcare Conference

EDINBURGH, United Kingdom, Nov. 28, 2018 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA), a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients...

NuCana plc: NuCana Reports Third Quarter 2018 Financial Results and Provides Business Update

Favorable Data Presented at ESMO on NUC-1031 (Acelarin) and NUC-3373 First Patients Enrolled in Phase Ib Study of NUC-3373 in Advanced Colorectal Cancer Initiation of Phase III Study of Acelarin in...

NuCana plc: NuCana Reports Additional Promising Clinical Data on NUC-1031 (Acelarin) as Front-Line Treatment of Advanced Biliary Tract Cancer at ESMO 2018

50% Objective Response Rate on Intent-to-Treat Basis Observed Phase III Study of Acelarin in Front-Line Advanced Biliary Tract Cancer Planned EDINBURGH, United Kingdom, Oct. 21, 2018 (GLOBE NEWSWIR...

NuCana raises US$114m in IPO of ADSs

NuCana: Explicating The Prospects Of A Novel Approach To Managing Cancers

How A Small Scottish Biotech Firm Could Win A Decisive Battle Against Cancer?

Nasdaq-listed Nucana has some promising cancer therapies in drug trials and an experienced leader.

EBS Opens Wallet, OPNT Surges In After-hours, Busy Months Ahead For NCNA

Today's Daily Dose brings you news about Emergent BioSolutions' acquisition of privately-held Adapt Pharma; anticipated milestones of NuCana, and second quarter financial results of Tilray.

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

NuCana

NuCana® is a rapidly growing, clinical stage biopharmaceutical company with a broad development portfolio of novel anti-cancer medicines. The Company’s proprietary ProTide...

More Information about "NuCana" on BioPortfolio

We have published hundreds of NuCana news stories on BioPortfolio along with dozens of NuCana Clinical Trials and PubMed Articles about NuCana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NuCana Companies in our database. You can also find out about relevant NuCana Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record